Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial

NCT02885545 is registered in ClinicalTrials.gov with Population Health Research Institute as lead sponsor.

NCT NCT02885545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02885545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial
Lead sponsor
Population Health Research Institute
Phase
Phase 4
Overall status
Withdrawn
Start date
September 30, 2016
Completion date
March 5, 2018
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute bleeding, cerebrovascular stroke, chronic kidney disease